New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 15, 2014
14:00 EDTCNMDCONMED receives notice of intent to nominate candidates from Voce Capital
CONMED confirmed receipt of notice from Voce Capital Management of its intention to nominate James W. Green, Alan L. Kaganov, Joshua H. Levine, Jeffrey M. Nugent, and J. Daniel Plants to stand for election to the company's Board of Directors at the 2014 Annual Meeting of Shareholders. CONMED shareholders are not required to take any action at this time. CONMED has determined to postpone the record date for its 2014 Annual Meeting of Shareholders and expects that the new record date will be announced in a future press release. Further details regarding the 2014 Annual Meeting of Shareholders, including the date, which is expected to be no later than July 31 will be included in the company's preliminary proxy statement, which will be mailed to shareholders of record in advance of the meeting. CONMED will present its formal recommendation regarding director nominations in its definitive proxy statement to be filed with the SEC and will provide shareholders with proxy materials, including a proxy card, in connection with the 2014 Annual Meeting of Shareholders in due course.
News For CNMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
08:23 EDTCNMDCONMED price target raised to $56 from $46 at Summer Street
Summer Street raised its price target for CONMED shares to $56 following the company's Q4 results and reiterates a Buy rating on the stock.
January 27, 2015
16:27 EDTCNMDCONMED sees revenue growth accelerating in 2H15
CONMED has outlined certain changes in the structure of its commercial organization that management believes will return the company to sales growth in 2015. The company anticipates constant currency sales growth of 1% to 3% for the full year, which will be driven by new product launches and a reorganization of certain aspects of the commercial sales organization in early 2015. As a result, management expects revenue growth to accelerate in the second half of 2015 compared to the first half of 2015.
16:05 EDTCNMDCONMED sees FY15 adjusted EPS $1.82-$1.92, consensus $2.02
Sees FY15 revenue $727M-$742M, consensus $749.92M.
16:04 EDTCNMDCONMED sees FY15 constant currency sales growth of 1%-3%
Subscribe for More Information
16:03 EDTCNMDCONMED reports Q4 adjusted EPS 53c, consensus 54c
Reports Q4 revenue $195M, consensus $196M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use